STOCK TITAN
  1. Home
  2. Sec-filings
  3. EVH
  4. [Form 4] Evolent Health, Inc. Insider Trading Activity

Evolent Health (EVH) director Russell Glass receives 41,096 restricted stock units

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Glass Russell Monroe reported acquisition or exercise transactions in this Form 4 filing.

Evolent Health, Inc. director Russell Monroe Glass reported an equity award of 41,096 shares of Class A Common Stock in the form of restricted stock units granted at $0.00 per share under the company’s 2015 Omnibus Incentive Compensation Plan. These RSUs vest on the earlier of June 4, 2027 or the company’s 2027 annual meeting, subject to his continued service. Following the award, he directly owns 77,347 shares and indirectly holds 6,046 shares through a trust he and his spouse co‑trustee and over which they share voting and dispositive power.

Positive

  • None.

Negative

  • None.
Insider Glass Russell Monroe
Role null
Type Security Shares Price Value
Grant/Award Class A Common Stock 41,096 $0.00 --
holding Class A Common Stock -- -- --
Holdings After Transaction: Class A Common Stock — 77,347 shares (Direct, null); Class A Common Stock — 6,046 shares (Indirect, By trust)
Footnotes (1)
  1. Represents restricted stock units granted to Mr. Glass pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. Securities vest on the earlier of June 4, 2027, and the date of the Company's 2027 annual meeting, subject to the reporting person's continued service on the vesting date. These shares are held in a trust for the benefit of the reporting person and his spouse. The reporting person and his spouse are co-trustees of the trust and share voting and dispositive power over the shares.
RSUs granted 41,096 shares Restricted stock units granted on June 4, 2026
Grant price $0.00 per share Price for RSU grant under 2015 Omnibus Plan
Direct holdings after grant 77,347 shares Class A Common Stock directly owned after transaction
Indirect trust holdings 6,046 shares Held in trust where Glass and spouse are co‑trustees
Vesting date June 4, 2027 or 2027 annual meeting Earlier of the two dates, subject to continued service
restricted stock units financial
"Represents restricted stock units granted to Mr. Glass pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan financial
"Represents restricted stock units granted to Mr. Glass pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan."
vest financial
"Securities vest on the earlier of June 4, 2027, and the date of the Company's 2027 annual meeting, subject to the reporting person's continued service on the vesting date."
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
co-trustees financial
"The reporting person and his spouse are co-trustees of the trust and share voting and dispositive power over the shares."
voting and dispositive power financial
"The reporting person and his spouse are co-trustees of the trust and share voting and dispositive power over the shares."
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Glass Russell Monroe
(Last)(First)(Middle)
C/O EVOLENT HEALTH, INC.
1812 N. MOORE ST., STE. 1705
(Street)
ARLINGTON VIRGINIA 22209
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Evolent Health, Inc. [ EVH ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/04/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock(1)06/04/2026A41,096(2)A$077,347D
Class A Common Stock6,046IBy trust(3)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents restricted stock units granted to Mr. Glass pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
2. Securities vest on the earlier of June 4, 2027, and the date of the Company's 2027 annual meeting, subject to the reporting person's continued service on the vesting date.
3. These shares are held in a trust for the benefit of the reporting person and his spouse. The reporting person and his spouse are co-trustees of the trust and share voting and dispositive power over the shares.
Remarks:
/s/ Jonathan Weinberg, Attorney-in-fact06/08/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Russell Monroe Glass report in this Evolent Health (EVH) Form 4?

Russell Monroe Glass reported receiving 41,096 restricted stock units of Evolent Health Class A Common Stock as an equity award. The grant was made at $0.00 per share under the company’s 2015 Omnibus Incentive Compensation Plan as part of his director compensation.

When do Russell Monroe Glass’s new Evolent Health (EVH) RSUs vest?

The 41,096 restricted stock units vest on the earlier of June 4, 2027, or the date of Evolent Health’s 2027 annual meeting. Vesting remains subject to Glass’s continued service with the company through the applicable vesting date, according to the disclosed grant terms.

How many Evolent Health (EVH) shares does Russell Monroe Glass own after this Form 4?

After the reported transactions, Russell Monroe Glass directly owns 77,347 shares of Evolent Health Class A Common Stock. He also indirectly holds 6,046 additional shares through a trust, where he and his spouse act as co‑trustees sharing voting and dispositive power.

What type of transaction is reported for Russell Monroe Glass’s Evolent Health (EVH) award?

The filing reports a grant or award acquisition of 41,096 shares, coded as an “A” transaction. This represents restricted stock units granted as compensation, not an open‑market purchase or sale, and therefore does not reflect a discretionary buy or sell decision.

How are the trust-held Evolent Health (EVH) shares controlled by Russell Monroe Glass?

The 6,046 Evolent Health shares are held in a trust for the benefit of Glass and his spouse. They serve as co‑trustees of the trust and share both voting and dispositive power over these shares, giving them joint control over trust-held holdings.